CERT vs UTHR · rev $385.1M vs P/E 20, rev $2.88B
Certara Inc (CERT) versus United Therapeutics Corporation (UTHR) — a side-by-side from cached financials, not a winner call.
Certara Inc (CERT) is a health information services company listed on US.
United Therapeutics Corporation (UTHR) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported CERT revenue for 2024-12-31 was $385.1M. Net income was -$12.1M. Revenue was up 8.7% from 2023-12-31 to 2024-12-31. CERT currently screens at market cap $1.86B.
Latest reported UTHR revenue for 2024-12-31 was $2.88B. Net income was $1.20B. Revenue was up 23.6% from 2023-12-31 to 2024-12-31. UTHR currently screens at market cap $23.41B and trailing P/E 20.4.
CERT currently screens at market cap $1.86B. UTHR currently screens at market cap $23.41B and trailing P/E 20.4.
Not investment advice. Open the CERT and UTHR stock pages for the full models.
Not investment advice.